The Relationship Between Multiple Obesity Indices and Long-Term Prognosis in STEMI Patients: An Observational Cohort Study of 220 Cases
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

ST-elevation myocardial infarction
Central obesity
Body mass index
Risk stratification

DOI

10.26689/jcnr.v8i9.8049

Submitted : 2024-08-28
Accepted : 2024-09-12
Published : 2024-09-27

Abstract

Objective: To investigate the association of body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) with the long-term prognosis of ST-elevation myocardial infarction (STEMI) patients and to determine whether the combination of obesity indices can be used for risk stratification. Method: A multifactorial Cox regression analysis was performed using 3-year follow-up data from 220 STEMI patients to explore the relationship between obesity indicators and major adverse cardiovascular events (MACEs). The incidence of MACEs was also compared by combining BMI and WHtR. Results: WC was found to reduce the risk of MACEs within 25 months after myocardial infarction [hazard ratio (HR) = 0.95, 95% confidence interval (CI) = 0.92–0.98, P < 0.001]. However, this effect was not significant beyond 25 months (HR = 0.98, 95% CI = 0.97–1.07, P = 0.49). Neither BMI nor WHtR were significantly associated with the risk of MACEs. The incidence of MACEs was highest in patients with low body weight (BMI < 18.5 kg/m2) and WHtR > 0.5, and lowest in obese patients (BMI ≥ 28 kg/m2) with WHtR > 0.5. Conclusions: BMI, WC, and WHtR were not significantly associated with the long-term prognosis of STEMI patients. However, the combination of BMI and WHtR can be useful for further stratifying patient risk.

References

Wang Y, Wang L, Qu W, 2017, New National Data Show Alarming Increase in Obesity and Noncommunicable Chronic Diseases in China. Eur J Clin Nutr, 71(1): 149–150. https://doi.org/10.1038/ejcn.2016.171

Benjamin EJ, Virani SS, Callaway CW, et al., 2018, Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation, 137(12): e67–e492. https://doi.org/10.1161/CIR.0000000000000558. Erratum in Circulation, 137(12): e493. https://doi.org/10.1161/CIR.0000000000000573

Piepoli MF, Hoes AW, Agewall S, et al., 2016, 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of 10 Societies and by Invited Experts) Developed with the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 37(29): 2315–2381. https://doi.org/10.1093/eurheartj/ehw106

Niedziela J, Hudzik B, Niedziela N, et al., 2014, The Obesity Paradox in Acute Coronary Syndrome: A Meta-Analysis. Eur J Epidemiol, 29(11): 801–812. https://doi.org/10.1007/s10654-014-9961-9

Zeller M, Steg PG, Ravisy J, et al., 2008, Relation Between Body Mass Index, Waist Circumference, and Death After Acute Myocardial Infarction. Circulation, 118(5): 482–490. https://doi.org/10.1161/CIRCULATIONAHA.107.753483

Coutinho T, Goel K, Correa de Sa D, et al., 2013, Combining Body Mass Index with Measures of Central Obesity in the Assessment of Mortality in Subjects with Coronary Disease: Role of “Normal Weight Central Obesity”. J Am Coll Cardiol, 61(5): 553–560. https://doi.org/10.1016/j.jacc.2012.10.035. Erratum in J Am Coll Cardiol, 62(3): 261.

Kadakia MB, Fox CS, Scirica BM, et al., 2011, Central Obesity and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome: Observations from the MERLIN-TIMI 36 Trial. Heart, 97(21): 1782–1787. https://doi.org/10.1136/heartjnl-2011-300231

Lee SH, Park JS, Kim W, et al., 2008, Impact of Body Mass Index and Waist-to-Hip Ratio on Clinical Outcomes in Patients with ST-Segment Elevation Acute Myocardial Infarction (From the Korean Acute Myocardial Infarction Registry). Am J Cardiol, 102(8): 957–965. https://doi.org/10.1016/j.amjcard.2008.06.022

Dong S, Ji W, Zeng S, et al., 2020, Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised. J Cardiovasc Transl Res, 13(6): 916–927. https://doi.org/10.1007/s12265-020-10015-6

Qu Zhen LH, Song YF, 2021, Clinically Based Multidisciplinary Diagnosis and Treatment Consensus 30 for Obesity (2021 Edition). Chinese Electronic Journal of Obesity and Metabolic Diseases, 23(2): 183–191.

Browning LM, Hsieh SD, Ashwell M, 2010, A Systematic Review of Waist-to-Height Ratio as A Screening Tool for the Prediction of Cardiovascular Disease and Diabetes: 0·5 Could Be A Suitable Global Boundary Value. Nutr Res Rev, 23(2): 247–269. https://doi.org/10.1017/S0954422410000144

Neeland IJ, Das SR, Simon DN, et al., 2017, The Obesity Paradox, Extreme Obesity, and Long-Term Outcomes in Older Adults with ST-Segment Elevation Myocardial Infarction: Results from the NCDR. Eur Heart J Qual Care Clin Outcomes, 3(3): 183–191. https://doi.org/10.1093/ehjqcco/qcx010

Kwon H, Yun JM, Park JH, et al., 2021, Incidence of Cardiovascular Disease and Mortality in Underweight Individuals. J Cachexia Sarcopenia Muscle, 12(2): 331–338. https://doi.org/10.1002/jcsm.12682